Results for:(60 found)
Feb 2, 2012 7:39PM on Top StocksBy Benzinga

The company's Bydureon diabetes shot finally gets the green light from regulators.

Feb 1, 2012 11:42AM on Top StocksBy MSN Money Partner

Seagate is upgraded to 'overweight,' while T. Rowe Price is downgraded to 'sell.'

Jan 30, 2012 3:13PM on Top StocksBy Minyanville

U.S. clearance is a major milestone, but Bydureon faces stiff competition from its fast-selling rival.

Jan 27, 2012 1:00PM on Top StocksBy MoneyShow.com

Some of the biggest and highest-yielding drug stocks are declining near attractive buy levels.

Jan 26, 2012 5:33PM on Top StocksBy InvestorPlace

These picks fit the bill in a sector with great long-term prospects.

Jan 24, 2012 2:57PM on Top StocksBy MSN Money Partner

However you slice it, J&J's prospect of earnings growth looks bleak as economic and competitive 'headwinds' continue.

Jan 16, 2012 9:08AM on Top StocksBy MSN Money Partner

The drugmaker is creating a buzz because of its recently approved blood cancer treatment and its potential as a buyout candidate..

Jan 13, 2012 7:13PM on Top StocksBy InvestorPlace

When you see all-too-rare sell calls, you'd better duck and cover.

VIDEO ON MSN MONEY

DATA PROVIDERS

Copyright © 2013 Microsoft. All rights reserved.

Quotes are real-time for NASDAQ, NYSE and AMEX. See delay times for other exchanges.

Fundamental company data and historical chart data provided by Thomson Reuters (click for restrictions). Real-time quotes provided by BATS Exchange. Real-time index quotes and delayed quotes supplied by Interactive Data Real-Time Services. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by SIX Financial Information.

Japanese stock price data provided by Nomura Research Institute Ltd.; quotes delayed 20 minutes. Canadian fund data provided by CANNEX Financial Exchanges Ltd.

MARKET DISPATCHES

No more Dispatches; here's where to find market news

The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.

More

SMART SPENDING

Tornado spawns scam warnings

Take an extra step before donating to a charity that claims to be helping tornado victims: Research them first.

More

SMART TAXES

More